Loading...
A potential therapeutic target for FLT3-ITD AML: PIM1 Kinase
Patients with acute myeloid leukemia (AML) and a FLT3 internal tandem duplication (ITD) mutation have a poor prognosis, and FLT3 inhibitors are now under clinical investigation. PIM1, a serine/threonine kinase, is up-regulated in FLT3-ITD AML and may be involved in FLT3-mediated leukemogenesis. We e...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3380375/ https://ncbi.nlm.nih.gov/pubmed/21802138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2011.07.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|